ArticleScientific reports2025
Association between serum high-sensitivity C-reactive protein levels and osteoarthritis in adults from NHANES 2015 to 2018.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association between the systemic immune-inflammation index and risk of osteoarthritis: a cross-sectional NHANES 2013-2018 study.Clinical rheumatology · 2026Article
- Comparative Analysis of Aging-related Metabolic and Biological Markers between Cancer Survivors and Healthy Populations: A Systematic Review.Journal of cancer prevention · 2025Review
- Senescence-driven osteonecrosis of the femoral head in the elderly-a distinct pathophysiological entity.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To explore the association between serum high-sensitivity C-reactive protein (HSCRP) levels and osteoarthritis (OA) in adults, providing new evidence for the diagnosis of adult OA. We selected data from the 2015-2018 National Health and Nutrition Examination Survey (NHANES) and conducted a cross-sectional study. Serum HSCRP levels were extracted from laboratory data, and OA patients were identified through questionnaire responses. Participants under the age of 20 and those with incomplete data were excluded. We used multivariable logistic regression models, restricted cubic spline (RCS) functions, and stratified analyses to study the association between serum HSCRP levels and osteoarthritis in adults. After screening, a total of 9,948 participants were included, among whom 1,196 were osteoarthritis patients, representing a prevalence rate of 12.02%. Multivariable logistic regression analysis, along with three adjusted models, showed a positive correlation between serum HSCRP levels and the occurrence of osteoarthritis in adults. Compared to the lowest HSCRP quartile, the highest quartile showed a 1.86-fold higher prevalence of OA (95% confidence interval: 1.55 ~ 2.23, P < 0.001). The restricted cubic spline analysis showed a significant increase in OA incidence with rising serum HSCRP levels (P < 0.05). Subgroup and forest plot analyses indicated a positive correlation between HSCRP levels and osteoarthritis across different subgroups, such as age, gender, hypertension status, activity status, drinking status, and Smoke status (P < 0.05). There is a positive correlation between serum HSCRP levels and the occurrence of osteoarthritis in adults. When a patient's serum HSCRP level is elevated, the possibility of osteoarthritis should be considered.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.